For pharmacy leaders responsible for sterile compounding oversight, understanding the role of compendial microbiologic testing is essential. Pharmetric Laboratory provides Compendial Sterility Testing performed in compliance with USP <71>, a long-established method that has served as the industry’s foundational sterility verification standard since its introduction in 1932. While modern rapid microbiological methods continue to evolve, USP <71> remains the recognized “policing” test referenced across regulatory and quality assurance frameworks. For decision-makers, this means the method continues to play an important role in validating the safety of sterile preparation and supporting regulatory compliance.

From an operational standpoint, compendial sterility testing helps pharmacies verify that sterile compounded products meet the required microbiological standards before they reach patients. The process follows the procedures outlined in USP <71>, which includes specific testing parameters detailed in Tables 1, 2, and 3. Pharmacy leadership should also be aware that method suitability testing is strongly recommended, as it confirms that the testing approach can reliably detect microorganisms in the specific formulation being evaluated. This step helps reduce the risk of false negatives and strengthens the overall quality assurance process.

For pharmacies navigating compliance expectations, the continued use of USP-based sterility testing supports both regulatory readiness and patient safety initiatives. Reliable sterility verification contributes to stronger risk management practices and helps ensure compounded sterile preparations maintain the integrity required for safe administration. As pharmacy operations grow more complex, decision-makers often rely on established compendial methods, such as USP <71>, to reinforce quality systems while maintaining confidence in sterile product testing workflows.